NCT04220658 - Biomarker Study to Evaluate Correlations Between Epigenetic Aging and NAD+ Levels in Healthy Volunteers | Biotech Hunter

Enrollment

170

Participants

Timeline

Start Date

December 19, 2019

Primary Completion Date

December 1, 2023

Study Completion Date

December 3, 2023

Conditions

Epigenetics

Interventions

OTHER

Biomarker study

Biomarkers of aging including NAD+ levels in whole blood, interleukins, inflammatory cytokines, growth factors, omega-3 polyunsaturated fatty acids, and patterns in DNA methylation

Trial Locations (1)

27710

Duke Early Phase Clinical Research, Durham